|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS: | ||||||
| Deferred offering costs | ||||||
| Current assets: | ||||||
| Cash | ||||||
| Prepaid insurance - current | ||||||
| Prepaid expenses | ||||||
| Cash and cash equivalents | ||||||
| Receivables under collaboration agreements (includes $0 and $1,000 as related party as of June 30, 2026, and December 31, 2025, respectively) | ||||||
| Deferred transaction costs | ||||||
| Prepaid expenses and other current assets (includes $720 and $1,110 as related party as of June 30, 2026, and December 31, 2025, respectively) | ||||||
| Total current assets | ||||||
| Prepaid insurance - long term | ||||||
| Investments held in Trust Account | ||||||
| Restricted cash | ||||||
| Property and equipment, net | ||||||
| Operating lease right-of-use assets, net | ||||||
| Other non-current assets (related party) | ||||||
| Total Assets | ||||||
| Liabilities, Redeemable Convertible Preferred Stock & Stockholders’ Equity (Deficit) | ||||||
| Current liabilities: | ||||||
| Accrued offering costs | ||||||
| Accounts payable (includes $2 and $190 as related party, as of June 30, 2026, and December 31, 2025, respectively) | ||||||
| Accrued expenses | ||||||
| Promissory note - related party | ||||||
| Operating lease liabilities, current portion | ||||||
| Total current liabilities | ||||||
| Deferred underwriting fee | ||||||
| Operating lease liabilities, net of current portion | ||||||
| Convertible promissory notes – related parties, at fair value | ||||||
| Warrant liabilities | ||||||
| Series B-1 and Series D redeemable convertible preferred stock warrants | ||||||
| Warrants for Series A | ||||||
| Total liabilities | ||||||
| Redeemable convertible preferred stock | ||||||
| Series A-1 redeemable convertible preferred stock | ||||||
| Series A-2 redeemable convertible preferred stock | ||||||
| Series B-1 redeemable convertible preferred stock | ||||||
| Series C-1 redeemable convertible preferred stock | ||||||
| Series C-2 redeemable convertible preferred stock | ||||||
| Series D redeemable convertible preferred stock | ||||||
| Redeemable Class A | ||||||
| Total series D redeemable convertible preferred stock | ||||||
| Total redeemable convertible preferred stock | ||||||
| Stockholders’ equity (deficit): | ||||||
| Preferred stock, $0.00001 pare value, 100,000,000 authorized as of June 30, 2026. No shares were authorized as of December 31, 2025. | ||||||
| Common stock | ||||||
| Series A Common stock | ||||||
| Series B Common stock | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Accumulated other comprehensive loss | ||||||
| Total stockholders’ equity (deficit) | ||||||
| Total Liabilities, Redeemable Convertible Preferred Stock & Stockholders’ Equity (Deficit) | ||||||
| Common stock, par value (in usd per share) |
Loading...
